» Articles » PMID: 29909364

Semiquantitative Analysis Using Standardized Uptake Value in I-FP-CIT SPECT/CT

Overview
Journal Clin Imaging
Publisher Elsevier
Specialty Radiology
Date 2018 Jun 18
PMID 29909364
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate potential of a semiquantitative method using standardized uptake value (SUV) in I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (I-FP-CIT) single photon emission computed tomography/computed tomography (SPECT/CT) compared with specific binding ratio (SBR).

Materials And Methods: First, we performed a phantom study to validate the accuracy of measuring SUV. 52 patients (25 male, 27 female; mean age of 75.1-year-old; 40 and 12 patients with neurodegenerative diseases with or without presynaptic dopaminergic deficits, respectively) were enrolled in a retrospective study. We measured SBR, maximum SUV, peak SUV, mean SUV, and striatum-to-background ratio of SUV (SUV) for striatum with lower I-FP-CIT uptake using commercial software. We calculated Pearson's correlation coefficient between SBR and SUV. We also calculated the sensitivity, specificity, and accuracy of each parameter for differential diagnosis.

Results: The phantom study revealed errors of <10% between theoretical and actual SUVs. Although there were significant correlations between SBR and all SUV-based parameters, SUV showed the most strong correlation with SBR (r = 0.877, p < 0.001). However, diagnostic capability of SUV (cutoff = 2.35) yielded to that of SBR (cutoff = 3.90) for diagnosing neurodegenerative diseases with presynaptic dopaminergic deficits (sensitivity of 85.0% vs 92.5%, specificity of 100% vs 91.7%, and accuracy of 88.5% vs 92.3%, respectively).

Conclusion: SBR is a promising parameter to aid differential diagnosis of neurodegenerative diseases with or without presynaptic dopaminergic deficit. Although technically acceptable, SUV may not be superior to SBR when clinically applied in I-FP-CIT SPECT/CT.

Citing Articles

Comparison of the ability of different quantitative indices in I-FP-CIT single-photon emission computed tomography to differentiate dopaminergic neurodegenerative disease.

Sato T, Sawai S, Shimada N Jpn J Radiol. 2024; 43(1):78-90.

PMID: 39235674 PMC: 11717878. DOI: 10.1007/s11604-024-01648-7.


EANM practice guideline for quantitative SPECT-CT.

Dickson J, Armstrong I, Minguez Gabina P, Denis-Bacelar A, Krizsan A, Gear J Eur J Nucl Med Mol Imaging. 2022; 50(4):980-995.

PMID: 36469107 PMC: 9931838. DOI: 10.1007/s00259-022-06028-9.


Volumetric analysis of mandibular lesions with SPECT/CT: a pilot clinical study of maximum standardized uptake value.

Minami Y, Ogawa R, Ogura I Pol J Radiol. 2022; 87:e311-e315.

PMID: 35892069 PMC: 9288195. DOI: 10.5114/pjr.2022.117569.


Analysis of medication-related osteonecrosis of the jaw with bone SPECT/CT: relationship between patient characteristics and maximum standardized uptake value.

Ogawa R, Ogura I Dentomaxillofac Radiol. 2021; 50(8):20200516.

PMID: 34019434 PMC: 8611283. DOI: 10.1259/dmfr.20200516.


A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography.

Bando R, Otsuka H, Otani T, Matsuda N, Azane S, Kunikane Y Ann Nucl Med. 2021; 35(4):504-513.

PMID: 33630226 DOI: 10.1007/s12149-021-01592-w.